Inherited gynaecological cancers

被引:0
作者
George, Angela [1 ,2 ]
机构
[1] Royal Marsden NHS Fdn Trust, Gynaecol Unit, London, England
[2] Royal Marsden NHS Fdn Trust, Canc Genet Unit, London, England
关键词
BRCA1; BRCA2; cancer risk; immunotherapy; Lynch syndrome; PARP inhibitors; EPITHELIAL OVARIAN-CANCER; BRCA2 MUTATION CARRIERS; MAINTENANCE THERAPY; PHASE-3; TRIAL; DOUBLE-BLIND; SURVIVAL; WOMEN; TUMORS; ASSOCIATION; CARCINOMA;
D O I
10.1097/CCO.0000000000000465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of reviewThere is an increasing interest in the role of routine testing for germline mutations in the management and outcome of gynaecological cancers as the therapeutic options for these patients develop, and knowledge about specific gene risks increase. This review focuses on recent literature assessing these areas of interest.Recent findingsSystemic treatment options continue to increase, with two recent studies (SOLO2 and ARIEL-3) of the use of PARP inhibitors in the maintenance setting; and approval of pembrolizomab for mismatch repair deficient/microsatellite unstable tumours. Several studies have addressed the resultant increased demand for testing for Lynch syndrome and BRCA1/2 mutations in endometrial and ovarian cancers, respectively. Finally, several studies have assessed gene and age-specific risks for ovarian cancer, and the role of specific site mutations within BRCA2 in determining duration of PARP response, and clinical outcome.SummaryThe use of genomic information to guide treatment choices, and inform outcome is an exciting and rapidly expanding field. These recent studies provide additional support to suggest that testing for inherited mutations should be a routine part of care for these gynaecological patients care.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 28 条
[1]   A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer [J].
Adams, Sarah F. ;
Marsh, Evelyn B. ;
Elmasri, Wafic ;
Halberstadt, Steffanie ;
VanDecker, Stephanie ;
Sammel, Mary D. ;
Bradbury, Angela R. ;
Daly, Mary ;
Karlan, Beth ;
Rubin, Stephen C. .
GYNECOLOGIC ONCOLOGY, 2011, 123 (03) :486-491
[2]   Universal Screening of Both Endometrial and Colon Cancers Increases the Detection of Lynch Syndrome [J].
Adar, Tomer ;
Rodgers, Linda H. ;
Shannon, Kristen M. ;
Yoshida, Makoto ;
Ma, Tianle ;
Mattia, Anthony ;
Lauwers, Gregory Y. ;
Iafrate, Anthony J. ;
Hartford, Nicole M. ;
Oliva, Esther ;
Chung, Daniel C. .
CANCER, 2018, 124 (15) :3145-3153
[3]   BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group [J].
Alsop, Kathryn ;
Fereday, Sian ;
Meldrum, Cliff ;
deFazio, Anna ;
Emmanuel, Catherine ;
George, Joshy ;
Dobrovic, Alexander ;
Birrer, Michael J. ;
Webb, Penelope M. ;
Stewart, Colin ;
Friedlander, Michael ;
Fox, Stephen ;
Bowtell, David ;
Mitchell, Gillian .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2654-2663
[4]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[5]   Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer [J].
Bolton, Kelly L. ;
Chenevix-Trench, Georgia ;
Goh, Cindy ;
Sadetzki, Siegal ;
Ramus, Susan J. ;
Karlan, Beth Y. ;
Lambrechts, Diether ;
Despierre, Evelyn ;
Barrowdale, Daniel ;
McGuffog, Lesley ;
Healey, Sue ;
Easton, Douglas F. ;
Sinilnikova, Olga ;
Benitez, Javier ;
Garcia, Maria J. ;
Neuhausen, Susan ;
Gail, Mitchell H. ;
Hartge, Patricia ;
Peock, Susan ;
Frost, Debra ;
Evans, Gareth ;
Eeles, Rosalind ;
Godwin, Andrew K. ;
Daly, Mary B. ;
Kwong, Ava ;
Ma, Edmond S. K. ;
Lazaro, Conxi ;
Blanco, Ignacio ;
Montagna, Marco ;
D'Andrea, Emma ;
Nicoletto, Maria Ornella ;
Johnatty, Sharon E. ;
Krueger, Susanne ;
Jensen, Allan ;
Hogdall, Estrid ;
Goode, Ellen L. ;
Fridley, Brooke L. ;
Loud, Jennifer T. ;
Greene, Mark H. ;
Mai, Phuong L. ;
Chetrit, Angela ;
Lubin, Flora ;
Hirsh-Yechezkel, Galit ;
Glendon, Gord ;
Andrulis, Irene L. ;
Toland, Amanda E. ;
Senter, Leigha ;
Gore, Martin E. ;
Gourley, Charlie ;
Michie, Caroline O. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04) :382-390
[6]   Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer [J].
Candido-dos-Reis, Francisco J. ;
Song, Honglin ;
Goode, Ellen L. ;
Cunningham, Julie M. ;
Fridley, Brooke L. ;
Larson, Melissa C. ;
Alsop, Kathryn ;
Dicks, Ed ;
Harrington, Patricia ;
Ramus, Susan J. ;
de Fazio, Anna ;
Mitchell, Gillian ;
Fereday, Sian ;
Bolton, Kelly L. ;
Gourley, Charlie ;
Michie, Caroline ;
Karlan, Beth ;
Lester, Jenny ;
Walsh, Christine ;
Cass, Ilana ;
Olsson, Hakan ;
Gore, Martin ;
Benitez, Javier J. ;
Garcia, Maria J. ;
Andrulis, Irene ;
Mulligan, Anna Marie ;
Glendon, Gord ;
Blanco, Ignacio ;
Lazaro, Conxi ;
Whittemore, Alice S. ;
McGuire, Valerie ;
Sieh, Weiva ;
Montagna, Marco ;
Alducci, Elisa ;
Sadetzki, Siegal ;
Chetrit, Angela ;
Kwong, Ava ;
Kjaer, Susanne K. ;
Jensen, Allan ;
Hogdall, Estrid ;
Neuhausen, Susan ;
Nussbaum, Robert ;
Daly, Mary ;
Greene, Mark H. ;
Mai, Phuong L. ;
Loud, Jennifer T. ;
Moysich, Kirsten ;
Toland, Amanda E. ;
Lambrechts, Diether ;
Ellis, Steve .
CLINICAL CANCER RESEARCH, 2015, 21 (03) :652-657
[7]   Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Coleman, Robert L. ;
Oza, Amit M. ;
Lorusso, Domenico ;
Aghajanian, Carol ;
Oaknin, Ana ;
Dean, Andrew ;
Colombo, Nicoletta ;
Weberpals, Johanne, I ;
Clamp, Andrew ;
Scambia, Giovanni ;
Leary, Alexandra ;
Holloway, Robert W. ;
Amenedo Gancedo, Margarita ;
Fong, Peter C. ;
Goh, Jeffrey C. ;
O'Malley, David M. ;
Armstrong, Deborah K. ;
Garcia-Donas, Jesus ;
Swisher, Elizabeth M. ;
Floquet, Anne ;
Konecny, Gottfried E. ;
McNeish, lain A. ;
Scott, Clare L. ;
Cameron, Terri ;
Maloney, Lara ;
Isaacson, Jeff ;
Goble, Sandra ;
Grace, Caroline ;
Harding, Thomas C. ;
Raponi, Mitch ;
Sun, James ;
Lin, Kevin K. ;
Giordano, Heidi ;
Ledermann, Jonathan A. .
LANCET, 2017, 390 (10106) :1949-1961
[8]   Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].
Fong, Peter C. ;
Boss, David S. ;
Yap, Timothy A. ;
Tutt, Andrew ;
Wu, Peijun ;
Mergui-Roelvink, Marja ;
Mortimer, Peter ;
Swaisland, Helen ;
Lau, Alan ;
O'Connor, Mark J. ;
Ashworth, Alan ;
Carmichael, James ;
Kaye, Stan B. ;
Schellens, Jan H. M. ;
de Bono, Johann S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134
[9]   Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients [J].
George, Angela ;
Riddell, Daniel ;
Seal, Sheila ;
Talukdar, Sabrina ;
Mahamdallie, Shazia ;
Ruark, Elise ;
Cloke, Victoria ;
Slade, Ingrid ;
Kemp, Zoe ;
Gore, Martin ;
Strydom, Ann ;
Banerjee, Susana ;
Hanson, Helen ;
Rahman, Nazneen .
SCIENTIFIC REPORTS, 2016, 6
[10]   Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype [J].
Gourley, Charlie ;
Michie, Caroline O. ;
Roxburgh, Patricia ;
Yap, Timothy A. ;
Harden, Sharon ;
Paul, Jim ;
Ragupathy, Kalpana ;
Todd, Radha ;
Petty, Russell ;
Reed, Nick ;
Hayward, Richard L. ;
Mitchell, Paul ;
Rye, Tzyvia ;
Schellens, Jan H. M. ;
Lubinski, Jan ;
Carmichael, James ;
Kaye, Stan B. ;
Mackean, Melanie ;
Ferguson, Michelle .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15) :2505-2511